Background The rationale behind this update of the 2016 British Society for Rheumatology (BSR)
guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Background The rationale behind this update on the 2016 British Society for Rheumatology (BSR)
guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Hydroxychloroquine (HCQ) is a well-established drug used in the treatment of systemic lupus
erythematosus (SLE). Lupus UK, a national registered charity supporting people who have …

Advances in therapeutics, including a wider use of biologics and targeted synthetic disease-modifying
anti-rheumatic drugs (DMARDs) have substantially improved the management of …

SIR, Calcinosis is a debilitating manifestation of many connective tissue diseases, particularly
JDM and SSc. Little is known about the pathogenesis of this condition, and its treatment …

… Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley,
Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore …

Objectives Patients with Systemic Lupus Erythematosus are known to have dysregulated
immune responses and may have reduced response to vaccination against COVID-19 while …

… , Sofia Tosounidou, Maud van de Venne, Louise Warburton, David Wiliams, Chee-Seng
Yee, Caroline Gordon, Prescribing anti-rheumatic drugs in pregnancy and breastfeeding—the …

Rheumatoid arthritis (RA) is a chronic disease associated with significant morbidity. The
2009 NICE guidance advises on the management of patients with RA. In this study, we …

Objective To determine whether BILAG-2004 index is associated with the development of
damage in a cohort of SLE patients. Mortality and development of damage were examined. …